Khan Sadiq 4
4 · Tevogen Bio Holdings Inc. · Filed Jul 1, 2025
Insider Transaction Report
Form 4
Khan Sadiq
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-06-27+200,000→ 1,169,618 total
Footnotes (1)
- [F1]Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on June 27, 2030, provided that the reporting person remains in service with the Issuer at such dates.